NCT00526747已完成不适用
Novel Biomarkers of Erythropoietin Resistant Anemia Among Patients With Chronic Kidney Disease
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 试验地点
- 2
研究概览
简要总结
Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •prevalent patients greater than or equal to 18 years old with CKD defined as a glomerular filtration rate < 60 cc/min
排除标准
- •active GI bleeding or history of GI bleed in the prior 3 months
- •uncontrolled hyperparathyroidism (PTH>500)
- •untreated iron deficiency (transferrin saturation < 20% and ferritin < 100
- •overt infection
- •active hemolysis
- •hemoglobinopathies
- •known adverse response to erythropoietin
- •prior kidney transplant
- •aluminum toxicity
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
不适用
Novel Serum Biomarkers for Identifying Plaque Erosion in ACS and Predicting PrognosisPlaque RuptureAcute Coronary SyndromesNCT06763835Xuebo Liu301
Unknown
不适用
Studying Erythropoietin Receptor Presence and Function in Human Cancer SpecimensCancerNCT01827514Tel-Aviv Sourasky Medical Center500
Unknown
1 期
Evaluation of Erythroferrone as a New Biomarker of Erythropoesis Stimulating AgentsSports Drug AbuseNCT03276910Association Athletes For Transparency24
招募中
不适用
To Identify Primary Resistance to CDK4/6 Inhibitors in Breast CancerER Positive Breast CancerHER2-negative Breast CancerMetastatic Breast CancerNCT04660435Fondazione Sandro Pitigliani150
撤回
不适用
A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin AntibodiesAnemiaNCT00210977Johnson & Johnson Pharmaceutical Research & Development, L.L.C.